SANTA
CLARA, Calif., June 6, 2024
/PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer
in developing and marketing technology products and services to
healthcare providers to combat chronic diseases, today announced
that it has purchased an additional 247 bitcoins for an aggregate
$17 million in cash, inclusive of
fees and expenses.
As of June 6, 2024, Semler holds a
total of 828 bitcoins, which were acquired for an aggregate
$57 million, inclusive of fees and
expenses.
"Semler remains focused on our two strategies of expanding our
healthcare business and acquiring and holding
bitcoin," said Doug
Murphy-Chutorian, MD, Semler Scientific's chief
executive officer. "The company now holds 828 bitcoins,
underscoring our view that bitcoin is a compelling
investment and can serve as a reliable store of value. We will
continue to pursue our strategy of purchasing bitcoins with
cash."
About Semler Scientific, Inc:
Semler Scientific, Inc. develops, manufactures and markets
innovative products and services to combat chronic diseases. Its
flagship product, QuantaFlo®, which is patented and cleared by the
U.S. Food and Drug Administration (FDA), is a rapid point-of-care
test that measures arterial blood flow in the extremities. The
QuantaFlo test aids in the diagnosis of cardiovascular diseases,
such as peripheral arterial disease (PAD), and Semler Scientific is
seeking a new 510(k) clearance for expanded indications. QuantaFlo
is used by healthcare providers to evaluate their patient's risk of
mortality and major adverse cardiovascular events (MACE). Semler
Scientific also invests in bitcoin and has adopted
bitcoin as its primary treasury reserve asset.
Additional information about Semler Scientific can be found at
www.semlerscientific.com.
Forward-Looking Statements
This press release contains "forward-looking" statements. Such
statements can be identified by, among other things, the use of
forward-looking language such as the words "believe," "goal,"
"may," "will," "intend," "expect," "anticipate," "estimate,"
"project," "would," "could" or words with similar meaning or the
negatives of these terms or by the discussion of strategy or
intentions. The forward-looking statements in this release include
express or implied statements regarding the new
bitcoin strategy, the purchase of additional
bitcoin with cash, and the expansion of its healthcare
business, among others. Such forward-looking statements are subject
to a number of risks and uncertainties that could cause Semler
Scientific's actual results to differ materially from those
discussed here, such as risks inherent with investing in
bitcoin, including bitcoin's volatility;
risk of implementing a new treasury strategy; risk that insurance
plans and other customers will not continue to license its
cardiovascular testing products; risk of changes in the
reimbursement landscape for its customers including related to the
CMS rate announcement; risk of obtaining a new 510(k) clearance for
expanded indications; along with those other risk factors detailed
in Semler Scientific's filings with the Securities and Exchange
Commission. These forward-looking statements involve assumptions,
estimates, and uncertainties that reflect current internal
projections, expectations or beliefs. There can be no assurance
that such statements will prove to be accurate, and actual results
and future events could differ materially from those anticipated in
such statements. All forward-looking statements contained in this
press release are qualified in their entirety by these cautionary
statements and the risk factors described above. Furthermore, all
such statements are made as of the date of this release and Semler
Scientific assumes no obligation to update or revise these
statements unless otherwise required by law.
INVESTOR CONTACT:
Renae Cormier
Chief Financial Officer
ir@semlerscientific.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/semler-scientific-announces-additional-bitcoin-purchases-302166611.html
SOURCE Semler Scientific, Inc.